Lv3
317 积分 2022-09-29 加入
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response
12天前
已完结
Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
1个月前
已完结
Targeting NK cell CLEC12B enhances cancer immunotherapy
3个月前
已完结
Receptor-ubiquitination-targeting antibody-drug conjugates for enhanced endocytosis and lysosomal delivery
3个月前
已完结
Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations
3个月前
已完结
mRNA PROTACs: engineering PROTACs for high-efficiency targeted protein degradation
3个月前
已完结
Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease
3个月前
已完结
Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation
3个月前
已完结
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
6个月前
已完结
The E3 ubiquitin ligase ZNRF3 restricts WNT receptor complex activity by stimulating the selective degradation of WNT-engaged FZD
6个月前
已完结
皖公网安备34019202002308
